Print Page     Close Window     

SEC Filings

10-K/A
BIOTIME INC filed this Form 10-K/A on 04/02/2018
Entire Document
 
 

 

ONCOCYTE CORPORATION

STATEMENTS OF COMPREHENSIVE LOSS

(In thousands)

 

   Year Ended December 31, 
   2017   2016   2015 
             
NET LOSS  $(19,375)  $(11,168)  $(8,735)
Other comprehensive loss, net of tax:               
Realized loss on sale of available-for-sale securities   293    -    397 
Unrealized gain (loss) on available-for-sale securities   (527)   (304)   75 
COMPREHENSIVE LOSS  $(19,609)  $(11,472)  $(8,263)

 

The accompanying notes are an integral part of these financial statements.

 

   

© Copyright BioTime, Inc.